Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

Clinical trial NCT01800422 · UNKNOWN

Trial details

NCT number: NCT01800422
Sponsor: Northwestern University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer

Start date: 2013-06-01
Primary completion: 2021-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.